Erin D. Ellis

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

Rita Nanda, Minetta C. Liu, Christina Yau et al. · JAMA Oncology · 2020 · 706 citations · Full text

Medicine, Oncology, Pharmacology +16

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

Douglas Yee, Angela DeMichele, Christina Yau et al. · JAMA Oncology · 2020 · 225 citations · Full text

Medicine, Oncology, Breast Oncology +15

Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2.

Rita Nanda, Minetta C. Liu, Christina Yau et al. · Journal of Clinical Oncology · 2017 · 208 citations

Medicine, Oncology, Pharmacology +17

The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma.

Michelle M. Le Beau, MA Bitter, Richard A. Larson et al. · PubMed · 1989 · 181 citations

Life Sciences, Genetics, Oncology +14

SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma

Sudjit Luanpitpong, Jingting Li, Amruta Manke et al. · Oncogene · 2015 · 121 citations · Full text

Medicine, Cancer Biology, Oncology +16